FLOW CYTOMETRY MARKET ANALYSIS

Flow Cytometry is a laser-based technique which is used to detect and analyze chemical or physical characteristics of cells or particles, which is most commonly used to evaluate bone marrow, peripheral blood and other fluids in your body. Flow cytometry is continuously going through new developments with availability of robust photo detectors and new laser emitters, use of LED lamps as emitter, and changes in analytical capacity (multidimensional analysis software). Furthermore, new approaches combining existing technologies with routine laboratory procedures, such as imaging, which capture of images of cells possible in real time as they pass by the interrogation point are some of the major advancements in flow cytometry. The process also finds application in cytology, hematology, immunology, and microbiology, among other research fields

The global flow cytometry market is estimated to be valued at US$ 5,688.7 million in 2022 and is expected to exhibit a CAGR of 10.4% during the forecast period (2022-2030).

Figure 1. Global Flow Cytometry Market Share (%), by Technology, 2022

To learn more about this report, request a free sample copy

Global Flow Cytometry Market - Drivers

Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive the global flow cytometry market growth over the forecast period. For instance, in June 2022, BD, a medical technology company, announced that they had launched an advanced flow cytometry system that sort cells based on their inner workings. This system will sort and characterized the myriad cells that makes up the human body. It aims to profile individual cells based on their visual characteristics in addition to various protein biomarkers, at a rate of up to 15,000 cells per second.

Figure 2. Global Flow Cytometry Market Value (US$ Million), by Region, 2022

To learn more about this report, request a free sample copy

Global Flow Cytometry Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global flow cytometry market. For instance, in August 2020, according to the data published in Springer, flow cytometry analysis of peripheral blood mononuclear cell (PBMC) phenotype helped to predict the risk of clinical progression of COVID-19 and indicated that recovery from COVID-19 is accompanied by improved antigen presentation and more effective adaptive immune responses.

Global Flow Cytometry Market: Key Developments

Increasing adoption of inorganic strategies such as product launch by key market players is expected to drive global flow cytometry market. For instance, in June 2022, Sysmex Corporation, a medical device company, announced that they had launched XF-1600 flow cytometer that provides improved flexibility and efficiency for a wide range of applications in diagnostic applications.

Global Flow Cytometry Market: Restraint

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is expected to hinder the market growth. For instance, in November 2018, the U.S. Food and Drug Administration recalled a class I flow cytometers, which is manufactured by Beckman Coulter, Inc., a manufacturer of diagnostic systems. The flow cytometers was recalled due to electrical circuit error that deliver inaccurate assessments of cells taken from patients with blood cancers, HIV and other serious hematological diseases.

Global Flow Cytometry Market - Key Players

Major players operating in the global flow cytometry market include General Electric, BD, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH., Sysmex Corporation, Agilent Technologies, Inc., Danaher, Enzo Life Sciences, Inc., Cytek Biosciences, Sartorius AG, BioLegend, Inc., Beckman Coulter, Inc., Laboratory Corporation of America Holdings., and MilliporeSigma